139 related articles for article (PubMed ID: 26572968)
21. The Parkinson's disease-associated H50Q mutation accelerates α-Synuclein aggregation in vitro.
Ghosh D; Mondal M; Mohite GM; Singh PK; Ranjan P; Anoop A; Ghosh S; Jha NN; Kumar A; Maji SK
Biochemistry; 2013 Oct; 52(40):6925-7. PubMed ID: 24047453
[TBL] [Abstract][Full Text] [Related]
22. A new perspective in Parkinson's disease, chaperone-mediated autophagy.
Li B; Zhang Y; Yuan Y; Chen N
Parkinsonism Relat Disord; 2011 May; 17(4):231-5. PubMed ID: 21215675
[TBL] [Abstract][Full Text] [Related]
23. Site-specific fluorescence dynamics of α-synuclein fibrils using time-resolved fluorescence studies: effect of familial Parkinson's disease-associated mutations.
Sahay S; Anoop A; Krishnamoorthy G; Maji SK
Biochemistry; 2014 Feb; 53(5):807-9. PubMed ID: 24450731
[TBL] [Abstract][Full Text] [Related]
24. Understanding Caffeine's Role in Attenuating the Toxicity of α-Synuclein Aggregates: Implications for Risk of Parkinson's Disease.
Kardani J; Roy I
ACS Chem Neurosci; 2015 Sep; 6(9):1613-25. PubMed ID: 26167732
[TBL] [Abstract][Full Text] [Related]
25. The A53E α-synuclein pathological mutation demonstrates reduced aggregation propensity in vitro and in cell culture.
Rutherford NJ; Giasson BI
Neurosci Lett; 2015 Jun; 597():43-8. PubMed ID: 25892596
[TBL] [Abstract][Full Text] [Related]
26. Threonine 53 in alpha-synuclein is conserved in long-living non-primate animals.
Larsen K; Hedegaard C; Bertelsen MF; Bendixen C
Biochem Biophys Res Commun; 2009 Sep; 387(3):602-5. PubMed ID: 19619507
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of synphilin-1 promotes clearance of soluble and misfolded alpha-synuclein without restoring the motor phenotype in aged A30P transgenic mice.
Casadei N; Pöhler AM; Tomás-Zapico C; Torres-Peraza J; Schwedhelm I; Witz A; Zamolo I; De Heer R; Spruijt B; Noldus LP; Klucken J; Lucas JJ; Kahle PJ; Krüger R; Riess O; Nuber S
Hum Mol Genet; 2014 Feb; 23(3):767-81. PubMed ID: 24064336
[TBL] [Abstract][Full Text] [Related]
28. Creation of aggregation-defective α-synuclein variants by engineering the sequence connecting β-strand-forming domains.
Hernandez M; Golbert S; Zhang LG; Kim JR
Chembiochem; 2011 Nov; 12(17):2630-9. PubMed ID: 21998035
[TBL] [Abstract][Full Text] [Related]
29. Prion protein dynamics before aggregation.
Srivastava KR; Lapidus LJ
Proc Natl Acad Sci U S A; 2017 Apr; 114(14):3572-3577. PubMed ID: 28320943
[TBL] [Abstract][Full Text] [Related]
30. Controlling the mass action of alpha-synuclein in Parkinson's disease.
Kim C; Lee SJ
J Neurochem; 2008 Oct; 107(2):303-16. PubMed ID: 18691382
[TBL] [Abstract][Full Text] [Related]
31. Rescue of alpha-synuclein cytotoxicity by insulin-like growth factors.
Kao SY
Biochem Biophys Res Commun; 2009 Jul; 385(3):434-8. PubMed ID: 19470380
[TBL] [Abstract][Full Text] [Related]
32. Alpha-synuclein dysfunction in Lewy body diseases.
Tofaris GK; Spillantini MG
Mov Disord; 2005 Aug; 20 Suppl 12():S37-44. PubMed ID: 16092089
[TBL] [Abstract][Full Text] [Related]
33. The effect of diphenylethane side-chain substituents on dibenzocyclohexadiene formation and their inhibition of α-synuclein aggregation in vitro.
Bernardes G; Munir O; Krol ES
Bioorg Med Chem; 2023 Jan; 78():117147. PubMed ID: 36587551
[TBL] [Abstract][Full Text] [Related]
34. Intramolecular Diffusion in α-Synuclein: It Depends on How You Measure It.
Woodard J; Srivastava KR; Rahamim G; Grupi A; Hogan S; Witalka DJ; Nawrocki G; Haas E; Feig M; Lapidus LJ
Biophys J; 2018 Oct; 115(7):1190-1199. PubMed ID: 30224053
[TBL] [Abstract][Full Text] [Related]
35. Navigating the dynamic landscape of alpha-synuclein morphology: a review of the physiologically relevant tetrameric conformation.
Lucas HR; Fernández RD
Neural Regen Res; 2020 Mar; 15(3):407-415. PubMed ID: 31571649
[TBL] [Abstract][Full Text] [Related]
36. Multitude NMR studies of α-synuclein familial mutants: probing their differential aggregation propensities.
Bhattacharyya D; Kumar R; Mehra S; Ghosh A; Maji SK; Bhunia A
Chem Commun (Camb); 2018 Apr; 54(29):3605-3608. PubMed ID: 29568828
[TBL] [Abstract][Full Text] [Related]
37. Correction to Familial Mutations May Switch Conformational Preferences in α-Synuclein Fibrils.
Xu L; Ma B; Nussinov R; Thompson D
ACS Chem Neurosci; 2018 Jul; 9(7):1866-1867. PubMed ID: 29855185
[No Abstract] [Full Text] [Related]
38. Lives in the Balance: Why Do We Hold onto Potentially Harmful, Disease-Causing Mutations?
Caspermeyer J
Mol Biol Evol; 2016 Oct; 33(10):2765-6. PubMed ID: 27582520
[No Abstract] [Full Text] [Related]
39. Surface science: Separation by reconfiguration.
Field RW
Nature; 2012 Sep; 489(7414):41-2. PubMed ID: 22955609
[No Abstract] [Full Text] [Related]
40. Single-molecule FRET studies on alpha-synuclein oligomerization of Parkinson's disease genetically related mutants.
Tosatto L; Horrocks MH; Dear AJ; Knowles TP; Dalla Serra M; Cremades N; Dobson CM; Klenerman D
Sci Rep; 2015 Nov; 5():16696. PubMed ID: 26582456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
